title: Pityriasis rosea-like eruption associated with lamotrigine.
authors.forename: Evangelia
authors.initials: E
authors.lastname: Papadavid
authors.forename: Papadavid
authors.initials: P
authors.lastname: Evangelia
authors.forename: Ioannis
authors.initials: I
authors.lastname: Panayiotides
authors.forename: Panayiotides
authors.initials: P
authors.lastname: Ioannis
authors.forename: Michael
authors.initials: M
authors.lastname: Makris
authors.forename: Makris
authors.initials: M
authors.lastname: Michael
authors.forename: Sophia
authors.initials: S
authors.lastname: Giatrakou
authors.forename: Giatrakou
authors.initials: G
authors.lastname: Sophia
authors.forename: Maria
authors.initials: M
authors.lastname: Dalamaga
authors.forename: Dalamaga
authors.initials: D
authors.lastname: Maria
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Stavrianeas
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Stavrianeas
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Rigopoulos
authors.forename: Rigopoulos
authors.initials: R
authors.lastname: Dimitrios
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D020190:Myoclonic Epilepsy, Juvenile / Q000188:drug therapy; D017515:Pityriasis Rosea / Q000139:chemically induced*; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D014227:Triazines; D014635:Valproic Acid; D000077213:Lamotrigine